Analytical Data
-
Gene name
EphB4
-
简介
Ephb4 Protein, a receptor tyrosine kinase, plays a critical role in angiogenesis and development. Dysregulation of Ephb4 Protein has been associated with disorders like cancer and cardiovascular diseases. Targeting Ephb4 Protein may provide potential therapeutic interventions in these conditions by modulating angiogenesis, inhibiting tumor growth, and managing cardiovascular complications. EphB4 Protein, Mouse (HEK293, His) is the recombinant mouse-derived EphB4 protein, expressed by HEK293 , with C-His labeled tag.
- Application
-
Biological Activity
Immobilized Recombinant Mouse EphB4 is immobilized at 2 µg/mL(100 µL/well) can bind Mouse Ephrin-B2 (HY-P73017). The ED50 for this effect is 1.803 ng/mL. Immobilized Recombinant Mouse EphB4 is immobilized at 2 µg/mL (100 µL/well) can bind Mouse Ephrin-B2 (HY-P73017). The ED50 for this effect is 1.803 ng/mL.
-
Alternative Names
Ephrin type-B receptor 4; EPHB4; HTK; MYK1; TYRO11
-
Species
Mouse
-
Source
HEK293
-
Tag
C-His
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
P54761
-
Expression Region
L16-A539
-
AA Sequence
LEETLLNTKLETADLKWVTYPQAEGQWEELSGLDEEQHSVRTYEVCDMKRPGGQAHWLRTGWVPRRGAVHVYATIRFTMMECLSLPRASRSCKETFTVFYYESEADTATAHTPAWMENPYIKVDTVAAEHLTRKRPGAEATGKVNIKTLRLGPLSKAGFYLAFQDQGACMALLSLHLFYKKCSWLITNLTYFPETVPRELVVPVAGSCVANAVPTANPSPSLYCREDGQWAEQQVTGCSCAPGYEAAESNKVCRACGQGTFKPQIGDESCLPCPANSHSNNIGSPVCLCRIGYYRARSDPRSSPCTTPPSAPRSVVHHLNGSTLRLEWSAPLESGGREDLTYAVRCRECRPGGSCLPCGGDMTFDPGPRDLVEPWVAIRGLRPDVTYTFEVAALNGVSTLATGPPPFEPVNVTTDREVPPAVSDIRVTRSSPSSLILSWAIPRAPSGAVLDYEVKYHEKGAEGPSSVRFLKTSENRAELRGLKRGASYLVQVRARSEAGYGPFGQEHHSQTQLDESESWREQLA
-
Protein Length
Extracellular Domain
-
Molecular Weight
75 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EphB4 is a member of the Eph receptor tyrosine kinase family, which plays a critical role in developmental processes, cell migration, and the formation of various tissues. It interacts with its ligands, ephrin-B1 and ephrin-B2, to mediate bidirectional signaling pathways that influence cell positioning and communication during embryogenesis and in mature tissues. Research has indicated that EphB4 is implicated in several pathological conditions, including cancer metastasis, vascular formation, and neurological disorders. The overexpression or dysregulation of EphB4 in various cancers has drawn attention to its potential as a therapeutic target. Consequently, recombinant EphB4 protein has become a focus of study for understanding its functional mechanisms and interactions. By producing EphB4 in a recombinant form, researchers are able to investigate its role in cell signaling, elucidate its implications in disease, and explore its utility in therapeutic interventions. Studies utilizing the recombinant protein have provided insights into the modulation of tumor growth and angiogenesis, suggesting that targeting EphB4 signaling pathways may offer novel strategies for cancer treatment and tissue regeneration. As such, the investigation of EphB4 and its recombinant counterparts is significant for both fundamental biological research and the development of future therapeutic approaches.
